Smoking Cessation Options for Hospitalized Patients
Every hospitalized smoker should receive intensive bedside counseling combined with nicotine replacement therapy (NRT) or varenicline, with mandatory follow-up support extending at least one month after discharge. 1, 2
Core Intervention Components
In-Hospital Counseling
- Provide intensive bedside counseling to all hospitalized smokers regardless of admitting diagnosis, as this forms the foundation of effective cessation interventions. 1
- Set a definite quit date, ideally during hospitalization when smoking is already restricted. 1
- Emphasize complete abstinence as the goal rather than reduction. 1
- Check abstinence by measuring carbon monoxide in expired air to provide objective feedback. 1
- Hospitals should employ dedicated smoking cessation specialists to deliver this counseling, as routine staff advice alone is insufficient. 1
Pharmacotherapy Selection
First-line options (choose one):
Combination NRT (patch + short-acting form) is the most effective pharmacotherapy, achieving 31.5% cessation rates and showing a 54% increase over counseling alone (RR 1.54). 3, 2
Varenicline achieves 28% cessation rates and increases cessation 2-3 fold versus unassisted attempts. 3, 4
- Dosing: 0.5 mg once daily days 1-3, then 0.5 mg twice daily days 4-7, then 1 mg twice daily for 12 weeks 4
- Begin one week before quit date, or start during hospitalization with quit date between days 8-35 4
- Most common side effect is mild-to-moderate nausea (33% of patients, only 3% discontinue) 1
- Discontinue immediately if agitation, depressed mood, behavioral changes, or suicidal ideation occur 1
Bupropion SR is less effective (RR 1.04, not statistically significant over counseling alone) and should be reserved for patients who cannot tolerate NRT or varenicline. 2
- Contraindicated in seizure disorders, eating disorders, abrupt alcohol/benzodiazepine withdrawal 1
Critical Post-Discharge Support
The intervention fails without adequate follow-up. Counseling limited to the hospital stay shows no benefit; the effect depends entirely on post-discharge contact. 1, 2, 5
- Arrange weekly supportive contacts for at least 4 weeks after discharge, extending to one month minimum. 1, 2
- Schedule first follow-up within 2 weeks of discharge, then monthly contact for at least 4 months. 3
- Telephone counseling is as effective as face-to-face and removes barriers like cost and travel. 1
- Interactive voice response (IVR) systems are feasible but less effective than human counselor contact. 6
- Ensure primary care physician involvement in continued cessation support and medication management. 1
Special Populations
Cardiovascular Disease Patients
- Intensive intervention with counseling plus pharmacotherapy reduces all-cause mortality and hospital readmission rates over 2 years in patients admitted for cardiovascular disease. 2
- Smoking cessation reduces stroke recurrence risk by 36% and overall mortality by 25-50% after cardiovascular events. 3
- The same intensive intervention protocol applies (RR 1.42 for cessation). 2
Cancer Patients
- Continue offering smoking cessation throughout the entire oncology care continuum, including end-of-life care, with emphasis on patient preferences. 7
- Smoking worsens cancer prognosis, increases second primary tumors, reduces treatment effectiveness, and decreases quality of life across all cancer types. 1
- Cessation improves surgical outcomes, reduces pulmonary complications, and enhances chemotherapy/radiation effectiveness. 1
Renal Impairment
- No adjustment needed for mild-to-moderate renal impairment. 4
- Severe renal impairment (CrCl <30 mL/min): Varenicline 0.5 mg once daily, titrate to maximum 0.5 mg twice daily. 4
- End-stage renal disease on hemodialysis: Maximum varenicline 0.5 mg once daily. 4
Pregnant Smokers
- Provide intensive counseling to all pregnant smokers with clear information on fetal and maternal risks. 1
- Offer specialist smoking cessation support. 1
- Evidence for pharmacotherapy safety in pregnancy is insufficient; behavioral interventions are preferred. 1
Managing Nicotine Withdrawal During Hospitalization
Withdrawal symptoms peak within 24 hours, last acutely 3-4 days, and extend 3-4 weeks. 1
- Pharmacological treatment of withdrawal improves patient comfort, promotes post-discharge cessation, and increases compliance with hospital no-smoking policies. 1
- Assess all hospitalized smokers for withdrawal symptoms using the Fagerström Test for Nicotine Dependence (FTND) to determine appropriate NRT dosing. 1
- Withdrawal symptoms occur equally in high and low dependence smokers, so assess everyone. 1
- Cigarette craving peaks in the first week and may persist for months or years. 1
System-Level Requirements
- Document smoking status prominently in patient records at admission as a prerequisite for opportunistic intervention. 1
- List tobacco use on the admission problem list and as a discharge diagnosis. 1
- Hospitals should be completely smoke-free with strict policy enforcement. 1
- Provide written educational materials supplementing verbal counseling. 1
Common Pitfalls to Avoid
- Do not provide counseling without arranging post-discharge follow-up—this negates any benefit. 2, 5
- Do not rely on brief advice alone; intensive counseling is required. 2
- Do not withhold NRT from cardiovascular patients due to unfounded safety concerns. 3
- Do not assume motivated patients will succeed without pharmacotherapy—medication significantly increases success rates. 8
- Do not forget to facilitate prescription access and provide clear medication instructions including side effects. 1